Gene Therapy for Acquired and Genetic Cholestasis

Abstract excerpt

Cholestatic diseases can be caused by the dysfunction of transporters involved in hepatobiliary circulation. Although pharmacological treatments constitute the current standard of care for these diseases, none are curative, with liver transplantation being the only long-term solution for severe cholestasis, albeit with many disadvantages. Liver-directed gene therapy has shown promising results in clinical trials...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Hepatitis B Virus Studies
• Share to Pediatric Hepatobiliary Diseases and Treatments
• Share to Viral gastroenteritis research and epidemiology